Back
ESC Professional Premium Access

The first study to evaluate non-invasive haemodynamic profile changes in reaction to nitroglycerin in patients with HFmrEF in comparison to HFpEF and HFrEF.

Session: Pathophysiology and mechanisms of heart failure
Topic: Haemodynamics of Heart Failure
Speaker: Doctor R. Morawiec (Lodz, PL)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Robert Morawiec

Medical University of Lodz, Lodz (Poland)
1 presentation
0 follower

6 more presentations in this session

Comparative prognostic value of parameters of right ventricular pulsatile afterload in patients with advanced heart failure awaiting heart transplantation

Speaker: Doctor F. Rubino (Verona, IT)

Access
Abstract
Slides
Like
Thumbnail

Lung fluid levels estimated by remote dielectric sensingTM values and invasive hemodynamic measurements

Speaker: Doctor T. Imamura (Toyama, JP)

Access
Abstract
Slides
Like
Thumbnail

Pulmonary artery pressure-guided therapy in patients with heart failure using the CardioMEMS device and HF readmissions: analysis of the National Readmissions Database

Speaker: Assistant Professor A. Briasoulis (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

The hemodynamic and prognostic impact of systolic pressure change during right ventricular ejection in patients with HFREF

Speaker: Professor A. Schmeisser (Magdeburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Hemodynamics of acute decompensated heart failure in patients with very low NP levels.

Speaker: Doctor V. Subramanian (Dallas, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Pathophysiology and mechanisms of heart failure

Speakers: Doctor R. Morawiec, Doctor F. Rubino, Doctor T. Imamura, Assistant Professor A. Briasoulis, Professor A. Schmeisser...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources